Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy
Open Access
- 2 August 2017
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-7
Abstract
A balance between tumor invasion and immune defence system is widely investigated.Objective. The aim of this study was to evaluate lymphocyte phenotype in lymph nodes (LNs) of patients with lung cancer in relation to the presence of metastases.Methods. We investigated 364 LNs resected by transcervical extended mediastinal lymphadenectomy (TEMLA) of 49 patients with squamous cell carcinoma (SCC) or adenocarcinoma (AD) with (A) and without metastases (B). Expression of CD4, CD8, CD25, CTLA-4, and Foxp3 was assessed by immunohistochemical staining.Results. We observed a strong nuclear staining for Foxp3 in lymphocytes and cancer cells and strong membranous/cytoplasmatic reaction for CD4 and CD8, but low for CD25 and CTLA-4. There were significantly higher proportions of CD8+ cells in AD (B) versus AD (A) LNs (80% versus 52.5%,). The Foxp3/CD8 ratio was higher in AD (A) versus AD (B) LNs (0.4 versus 0.25,). No significant differences in the cell markers expression in SCC LNs were found.Conclusion. Significant differences in lymphocyte phenotype in AD may indicate an exceptional biology of this type of lung cancer. TEMLA resected LNs may serve as valuable samples for evaluation of immune status in lung cancer patients.
Keywords
This publication has 36 references indexed in Scilit:
- Trial watchOncoImmunology, 2012
- Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytesOncology Letters, 2012
- The immune score as a new possible approach for the classification of cancerJournal of Translational Medicine, 2012
- Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsLung Cancer, 2012
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive SummaryProceedings of the American Thoracic Society, 2011
- Cancer immunology—analysis of host and tumor factors for personalized medicineNature Reviews Clinical Oncology, 2011
- Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary AdenocarcinomaJournal of Thoracic Oncology, 2011
- FOXP3 Expression and Overall Survival in Breast CancerJournal of Clinical Oncology, 2009
- Foxp3 expression in human cancer cellsJournal of Translational Medicine, 2008
- Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patientsCancer, 2006